14-16 October 2026
Lisbon, Portugal
Call for abstracts will open on 27 January 2026.
Apply for oral or poster presentations.
The Champalimaud Research Symposium 2026
(CRSy26) will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.
Key topics will include mechanistic insights into neuro-immune signaling pathways, the influence of stress and innervation on tumor immunity, and how immune responses can affect neural activity within tumours and beyond.
(CRSy26) will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.
Key topics will include mechanistic insights into neuro-immune signaling pathways, the influence of stress and innervation on tumor immunity, and how immune responses can affect neural activity within tumours and beyond.
Symposium Chairs
Carlos Minutti
Immunoregulation Lab, Champalimaud Foundation, Lisbon, PT
Henrique Veiga-Fernandes Immunophysiology Lab, Champalimaud Foundation, Lisbon, PT
Carlos Minutti
Immunoregulation Lab, Champalimaud Foundation, Lisbon, PT
Henrique Veiga-Fernandes Immunophysiology Lab, Champalimaud Foundation, Lisbon, PT
Confirmed Keynote Speakers
Douglas Hanahan
EPFL, Lausanne, CH
Florent Ginhoux
Gustave Roussy, Villejuif, FR
Douglas Hanahan
EPFL, Lausanne, CH
Florent Ginhoux
Gustave Roussy, Villejuif, FR
CRSy is the main scientific symposium of the Champalimaud Research. Since 2017, it has fostered global dialogue among researchers across various disciplines, focusing on groundbreaking advancements in neuroscience, physiology and cancer.
Jesse Marshall, PhD
Meta Platforms Inc
New York, New York, USA
Jesse Marshall is a research scientist at Reality Labs where he works as part of the Neural Interfaces team. The team's goal is to research and productionize EMG-based control for computing devices. The highly interdisciplinary team works at the interface of hardware development, machine learning, and user experience design to develop novel intention decoding schemes using EMG signals. This work has led to the development of the first neuromotor interface capable of out-of-the-box control on novel subjects. Prior to Meta, Jesse completed his postdoctoral fellowship at Harvard working with Bence Olveczky at the intersection of behavioral tracking, motor learning and NeuroAI, and his PhD with Mark Schnitzer at Stanford.
︎ Learn more about the speaker here